Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wesam Bahitham

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Frontiers in Cardiovascular Medicine|April 11, 2019
The Impact of Natural Antioxidants on the Regenerative Potential of Vascular CellsShahida Shafi, Hifzur Rahman Ansari, Wesam Bahitham, et al.
Biochimica Et Biophysica Acta|March 16, 2016
Liver-specific expression of carboxylesterase 1g/esterase-x reduces hepatic steatosis, counteracts dyslipidemia and improves insulin signalingWesam Bahitham, Russell Watts, Randal Nelson, et al.
Frontiers in Bioscience (Elite Edition)|December 29, 2011
Mitochondrial DNA related cardiomyopathiesShamayel Mohammed, Wesam Bahitham, Alicia Chan, et al.
Congenital Heart Disease|October 21, 2011
Mitochondrial DNA depletion syndrome-an unusual reason for interstage attrition after the modified stage 1 Norwood operationDominic Cave, David B Ross, Wesam Bahitham, et al.
Annals of Clinical and Laboratory Science|February 20, 2015
Differential SIRT1 expression in hepatocellular carcinomas and cholangiocarcinoma of the liverRedha Al-Bahrani, Dominika Tuertcher, Samar Zailaie, et al.
Plos One|August 20, 2014
Mitochondriome and cholangiocellular carcinomaWesam Bahitham, Xiaoping Liao, Fred Peng, et al.
Biochimica Et Biophysica Acta. Molecular and Cell Biology of Lipids|April 10, 2018
Genetic variation in human carboxylesterase CES1 confers resistance to hepatic steatosisJihong Lian, Wesam Bahitham, Rashmi Panigrahi, et al.
Frontiers in Nutrition|September 26, 2025
"Trust your gut": exploring the connection between gut microbiome dysbiosis and the advancement of Metabolic Associated Steatosis Liver Disease (MASLD)/Metabolic Associated Steatohepatitis (MASH): a systematic review of animal and human studiesWesam Bahitham, Yusra Banoun, Mutep Aljahdali, et al.
Scientific Reports|July 26, 2017
Absence of Tissue Inhibitor of Metalloproteinase-4 (TIMP4) ameliorates high fat diet-induced obesity in mice due to defective lipid absorptionSiva S V P Sakamuri, Russell Watts, Abhijit Takawale, et al.
Biomedicines|March 28, 2024
Double Trouble: How Microbiome Dysbiosis and Mitochondrial Dysfunction Drive Non-Alcoholic Fatty Liver Disease and Non-Alcoholic SteatohepatitisWesam Bahitham, Siraj Alghamdi, Ibrahim Omer, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Frontiers in Cardiovascular Medicine|April 11, 2019
The Impact of Natural Antioxidants on the Regenerative Potential of Vascular CellsShahida Shafi, Hifzur Rahman Ansari, Wesam Bahitham, et al.
Biochimica Et Biophysica Acta|March 16, 2016
Liver-specific expression of carboxylesterase 1g/esterase-x reduces hepatic steatosis, counteracts dyslipidemia and improves insulin signalingWesam Bahitham, Russell Watts, Randal Nelson, et al.
Frontiers in Bioscience (Elite Edition)|December 29, 2011
Mitochondrial DNA related cardiomyopathiesShamayel Mohammed, Wesam Bahitham, Alicia Chan, et al.
Congenital Heart Disease|October 21, 2011
Mitochondrial DNA depletion syndrome-an unusual reason for interstage attrition after the modified stage 1 Norwood operationDominic Cave, David B Ross, Wesam Bahitham, et al.
Annals of Clinical and Laboratory Science|February 20, 2015
Differential SIRT1 expression in hepatocellular carcinomas and cholangiocarcinoma of the liverRedha Al-Bahrani, Dominika Tuertcher, Samar Zailaie, et al.
Plos One|August 20, 2014
Mitochondriome and cholangiocellular carcinomaWesam Bahitham, Xiaoping Liao, Fred Peng, et al.
Biochimica Et Biophysica Acta. Molecular and Cell Biology of Lipids|April 10, 2018
Genetic variation in human carboxylesterase CES1 confers resistance to hepatic steatosisJihong Lian, Wesam Bahitham, Rashmi Panigrahi, et al.
Frontiers in Nutrition|September 26, 2025
"Trust your gut": exploring the connection between gut microbiome dysbiosis and the advancement of Metabolic Associated Steatosis Liver Disease (MASLD)/Metabolic Associated Steatohepatitis (MASH): a systematic review of animal and human studiesWesam Bahitham, Yusra Banoun, Mutep Aljahdali, et al.
Scientific Reports|July 26, 2017
Absence of Tissue Inhibitor of Metalloproteinase-4 (TIMP4) ameliorates high fat diet-induced obesity in mice due to defective lipid absorptionSiva S V P Sakamuri, Russell Watts, Abhijit Takawale, et al.
Biomedicines|March 28, 2024
Double Trouble: How Microbiome Dysbiosis and Mitochondrial Dysfunction Drive Non-Alcoholic Fatty Liver Disease and Non-Alcoholic SteatohepatitisWesam Bahitham, Siraj Alghamdi, Ibrahim Omer, et al.
Pageof 2